HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José Luis Calleja Selected Research

Therapeutics

7/2014[Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José Luis Calleja Research Topics

Disease

2Infections
10/2019 - 07/2013
1Chronic Hepatitis C
10/2019
1Fibrosis (Cirrhosis)
07/2014

Drug/Important Bio-Agent (IBA)

2Antiviral Agents (Antivirals)IBA
10/2019 - 07/2013
2telaprevirIBA
07/2014 - 07/2013
1sofosbuvir velpatasvir voxilaprevir drug combinationIBA
10/2019
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
07/2014
1InterferonsIBA
07/2014
1Ribavirin (Virazole)FDA LinkGeneric
07/2014

Therapy/Procedure

1Therapeutics
07/2014